Beyond GLP-1: Leveraging Tissue-Specific Mitochondrial Uncoupling to Boost Energy Expenditure in Obesity Therapy
9:30 am - Tuesday 2nd December 2025
- Enhancing peptide stability and half-life for reduced dosing frequency to improve patient convenience for greater adherence
- Minimizing gastrointestinal side effects for improved patient comfort to increase treatment acceptance for wider clinical adoption
- Exploring novel delivery technologies for alternative administration routes to broaden patient access for diverse therapeutic needs